Scan-rescan measurement repeatability of 18F-FDG PET/MR imaging of vascular inflammation

被引:0
作者
Philip M. Robson
Audrey Kaufman
Alison Pruzan
Marc R. Dweck
Maria-Giovanna Trivieri
Ronan Abgral
Nicolas A. Karakatsanis
Patrick M. Brunner
Emma Guttman
Zahi A. Fayad
Venkatesh Mani
机构
[1] Icahn School of Medicine at Mount Sinai,BioMedical Engineering and Imaging Institute
[2] University of Edinburgh,British Heart Foundation/University Centre for Cardiovascular Science
[3] Icahn School of Medicine at Mount Sinai,Cardiovascular Institute
[4] European University of Brittany,Department of Nuclear Medicine
[5] EA3878 GETBO,Laboratory for Investigative Dermatology
[6] IFR 148,Department of Dermatology
[7] CHRU Brest,undefined
[8] The Rockefeller University,undefined
[9] Icahn School of Medicine at Mount Sinai,undefined
来源
Journal of Nuclear Cardiology | 2022年 / 29卷
关键词
PET/MR; F-FDG; vascular inflammation; scan-rescan; measurement repeatability;
D O I
暂无
中图分类号
学科分类号
摘要
Non-invasive positron emission tomography (PET) of vascular inflammation and atherosclerotic plaque by identifying increased uptake of 18F-fluordeoxyglucose (18F-FDG) is a powerful tool for monitoring disease activity, progression, and its response to therapy. 18F-FDG PET/computed tomography (PET/CT) of the aorta and carotid arteries has become widely used to assess changes in inflammation in clinical trials. However, the recent advent of hybrid PET/magnetic resonance (PET/MR) scanners has advantages for vascular imaging due to the reduction in radiation exposure and improved soft tissue contrast of MR compared to CT. Important for research and clinical use is an understanding of the scan-rescan repeatability of the PET measurement. While this has been studied for PET/CT, no data is currently available for vascular PET/MR imaging. In this study, we determined the scan-rescan measurement repeatability of 18F-FDG PET/MR in the aorta and carotid arteries was less than 5%, comparable to similar findings for 18F-FDG PET/CT.
引用
收藏
页码:1660 / 1670
页数:10
相关论文
共 50 条
  • [21] Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
    Benedikt M. Schaarschmidt
    Johannes Grueneisen
    Martin Metzenmacher
    Benedikt Gomez
    Thomas Gauler
    Christian Roesel
    Philipp Heusch
    Verena Ruhlmann
    Lale Umutlu
    Gerald Antoch
    Christian Buchbender
    European Radiology, 2017, 27 : 681 - 688
  • [22] Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels
    Bucerius, Jan
    Mani, Venkatesh
    Moncrieff, Colin
    Machac, Josef
    Fuster, Valentin
    Farkouh, Michael E.
    Tawakol, Ahmed
    Rudd, James H. F.
    Fayad, Zahi A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 369 - 383
  • [23] Diagnosis and prognostic predictive value of delineation methods from 18F-FDG PET/CT and PET/MR in pancreatic lesion
    Hu, Fan
    Zhang, Xiao
    Shu, Hua
    Wang, Xiaoli
    Feng, Shuqian
    Hu, Mengmeng
    Lan, Xiaoli
    Qin, Chunxia
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 13 (06): : 269 - 278
  • [24] Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation
    Blomberg, Bjoern A.
    Akers, Scott R.
    Saboury, Babak
    Mehta, Nehal N.
    Cheng, Gang
    Torigian, Drew A.
    Lim, Esther
    Del Bello, Catherine
    Werner, Thomas J.
    Alavi, Abass
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (09) : 860 - 867
  • [25] Detection of Adult Pancreatoblastoma by 18F-FDG and 68Ga-DOTATATE PET/MR
    Zhou, Jinxin
    Xie, Jing
    Pan, Yu
    Zhang, Yifan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : 671 - 674
  • [26] Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging
    Vlachopoulos, Charalambos V.
    Koutagiar, Iosif P.
    Georgakopoulos, Alexandros T.
    Pouli, Anastasia G.
    Sioni, Anastasia K.
    Chondropoulos, Spiros D.
    Solomou, Eirini G.
    Terentes-Printzios, Dimitrios G.
    Karakitsios, Ioannis G.
    Kafouris, Pavlos P.
    Gaitanis, Anastasios
    Pianou, Nikoletta K.
    Petrocheilou, Aikaterini
    Aggeli, Constantina, I
    Stroumpouli, Euaggelia
    Marinakis, Theodoros P.
    Voulgarelis, Michael
    Tousoulis, Dimitrios M.
    Anagnostopoulos, Constantinos D.
    JACC: CARDIOONCOLOGY, 2020, 2 (05): : 758 - 770
  • [27] 18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case
    Wang, Haiyan
    Xue, Qiaoyi
    You, Zhiwen
    Chen, Xing
    Yuan, Jianmin
    Zhao, Jun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1252 - 1253
  • [28] Abdominal and pelvic 18F-FDG PET/MR: a review of current and emerging oncologic applications
    Ryan D. Ward
    Barbara Amorim
    Weier Li
    Joseph King
    Lale Umutlu
    David Groshar
    Mukesh Harisinghani
    Onofrio Catalano
    Abdominal Radiology, 2021, 46 : 1236 - 1248
  • [29] 18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case
    Haiyan Wang
    Qiaoyi Xue
    Zhiwen You
    Xing Chen
    Jianmin Yuan
    Jun Zhao
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1252 - 1253
  • [30] Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma
    Gauthier Delaby
    Bahar Ataeinia
    Jennifer Wo
    Onofrio Antonio Catalano
    Pedram Heidari
    Abdominal Radiology, 2021, 46 : 3908 - 3916